These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2986368)

  • 1. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ; Bamrah V; Duthie E
    Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
    Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
    Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
    G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
    Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
    Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
    Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
    Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
    Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
    Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac amyloidosis].
    Jantunen E; Collan Y; Halinen MO; Kosma VM
    Duodecim; 1987; 103(4):192-8. PubMed ID: 3038501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
    Imamoto T; Morita K; Onodera S; Tanazawa S; Amoh K; Ishikawa Y; Murakami N; Kawachi H
    Kaku Igaku; 1988 Oct; 25(10):1117-23. PubMed ID: 2851670
    [No Abstract]   [Full Text] [Related]  

  • 13. A non-invasive approach to the diagnosis of amyloid cardiomyopathy in elderly patients.
    Ptacin M; Bamrah V; Sebastian J; Duthie E
    Mil Med; 1986 Feb; 151(2):104-7. PubMed ID: 3008031
    [No Abstract]   [Full Text] [Related]  

  • 14. Scintigraphic characterization of amyloid cardiomyopathy.
    Li CK; Rabinovitch MA; Juni JE; Thrall JH; Pitt B; Das SK; Abrams GD; Helvie M
    Clin Nucl Med; 1985 Mar; 10(3):156-9. PubMed ID: 2985318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A; Mahmood U; Tang X; Jain D; Pan S
    J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
    Hongo M; Hirayama J; Fujii T; Yamada H; Okubo S; Kusama S; Ikeda S
    Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
    Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
    Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
    Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
    Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.